BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 452090)

  • 1. Schizophrenia genetics complements its mechanistic understanding.
    Ruzzo EK; Geschwind DH
    Nat Neurosci; 2016 Apr; 19(4):523-5. PubMed ID: 26998600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-human histocompatibility antigen haplotypes in C2 deficiency.
    Awdeh ZL; Raum DD; Glass D; Agnello V; Schur PH; Johnston RB; Gelfand EW; Ballow M; Yunis E; Alper CA
    J Clin Invest; 1981 Feb; 67(2):581-3. PubMed ID: 7462431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited structural polymorphism of the fourth component of human complement.
    Awdeh ZL; Alper CA
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3576-80. PubMed ID: 6932037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations.
    Mauff G; Bender K; Giles CM; Goldmann S; Opferkuch W; Wachauf B
    Hum Genet; 1984; 65(4):362-72. PubMed ID: 6420328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of C4 null alleles on C4 activation in systemic lupus erythematosus.
    Briggs DC; Senaldi G; Isenberg DA; Welsh KI; Vergani D
    Ann Rheum Dis; 1991 Apr; 50(4):251-4. PubMed ID: 2029208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic control of Chido and Rodgers blood group substances.
    O'Neill GJ
    Semin Hematol; 1981 Jan; 18(1):32-8. PubMed ID: 7010610
    [No Abstract]   [Full Text] [Related]  

  • 7. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
    Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
    J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chido and Rodgers blood groups: relationship to C4 and HLA.
    O'Neill GJ; Yang SY; Dupont B
    Transplant Proc; 1978 Dec; 10(4):749-51. PubMed ID: 734745
    [No Abstract]   [Full Text] [Related]  

  • 9. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of the fourth component of human complement: population study and proposal for a revised nomenclature based on genomic PCR typing of Rodgers and Chido determinants.
    Schneider PM; Stradmann-Bellinghausen B; Rittner C
    Eur J Immunogenet; 1996 Oct; 23(5):335-44. PubMed ID: 8909940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C4 levels, Chido, Rodgers, and allotypes of C4 component of complement.
    O'Neill GJ; Dupont B
    Transplant Proc; 1979 Mar; 11(1):1102-6. PubMed ID: 452090
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic determinants of human C4, Rodgers and Chido.
    Giles CM
    Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.